Dyne Therapeutics Launches with $50 Million Series A to Develop Targeted Therapies for Muscle Diseases
FORCE™ platform of antibody conjugates will deliver nucleic acids and other molecules for the treatment of serious muscle diseases CAMBRIDGE,…
Pharmaceuticals, Biotechnology and Life Sciences
FORCE™ platform of antibody conjugates will deliver nucleic acids and other molecules for the treatment of serious muscle diseases CAMBRIDGE,…
BALERNA, Switzerland–(BUSINESS WIRE)–APR Applied Pharma Research’s patented formulation of Diclofenac 50 mg powder oral solution for migraine treatment and other…
EUR 21m Series A secured with international investor syndicate co-led by V-Bio Ventures (Belgium) and Advent France Biotechnology (France), and…
Successful manufacturing and release of GMP vials of UCARTCS1 NEW YORK–(BUSINESS WIRE)–Regulatory News: Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS),…
MONTREAL–(BUSINESS WIRE)–AmorChem, a leading venture fund dedicated to creating the next generation of biotech companies derived from academic research, introduced…
Analyses include the longest follow-up of lung cancer patients treated with Immuno-Oncology therapy in phase 3 randomized trials PRINCETON, N.J.–(BUSINESS…
HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products,…
MALVERN, Pa.–(BUSINESS WIRE)–Encore Dermatology Inc. announced today that it has acquired rights for SERNIVO® (betamethasone dipropionate) Spray, 0.05%, as well…
Biotech creating a new therapy for hot flashes in breast cancer patients launches clinical trials across United States ATLANTA–(BUSINESS WIRE)–Clinical…
AUSTIN, Texas & NEW YORK–(BUSINESS WIRE)–CDISC will develop the first global, non-proprietary clinical data standards for Crohn’s disease with a…